Press Release Archive
Press Releases
July 2023
07.18.2023
June 2023
06.28.2023
06.27.2023
06.26.2023
Research and Pipeline Research Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
06.23.2023
Prescription Medicines Medicines FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
06.22.2023
Financial Finance Pfizer Declares Third-Quarter 2023 Dividend
06.20.2023
Prescription Medicines Medicines Pfizer’s TALZENNA® in Combination with XTANDI® Receives U.S. FDA Approval
06.20.2023
06.06.2023
06.01.2023
May 2023
05.31.2023
05.30.2023
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.